Cell death and autophagy in prion diseases (transmissible spongiform encephalopathies)

Folia Neuropathologica

Volumn 46, Issue 1, 2008, Pages 1-25

  Liberski, Paweł P ^a   Brown, David R ^b   Sikorska, Beata ^a   Caughey, Byron ^c   Brown, Paul ^d  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b University of Bath   (United Kingdom)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NONE

Author keywords

Apoptosis; Autophagy; Neurons; Prion diseases; Ultrastructure

Indexed keywords

PRION PROTEIN; PROTEASOME;

AGGRESOME; AMINO ACID SEQUENCE; APOPTOSIS; AUTOPHAGY; CELL ULTRASTRUCTURE; CELL VACUOLE; CHROMOSOME 2; CYTOPATHOLOGY; CYTOTOXICITY; ENDOCYTOSIS; HUMAN; KURU; MOLECULAR CLONING; NERVE CELL MEMBRANE; NERVE CELL NECROSIS; NEUROAXONAL DYSTROPHY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERIKARYON; PRION; PRION DISEASE; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN VARIANT; REVIEW; SCRAPIE; SCRAPIE AGENT; VIRUS INFECTIVITY; VIRUS STRAIN;

EID: 42449158007     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Review

References (231)

1. Alper T, Cramp WA, Haig DA, Clarke MC. Does the agent of scrapie replicate without nucleic acid? Nature 1967; 214: 764-766.
2. Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC, Agid Y. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol 1997; 12: 25-31.
3. Baron GS, Magalhaes AC, Prado MA, Caughey B. Mouse-adapted scrapie infection of SN56 cells: greater efficiency with microsome-associated versus purified PrP-res. J Virol 2006; 80: 2106-2117.
4. Baron GS, Wehrly K, Dorward DW, Chesebro B, Caughey B. Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc)) into contiguous membranes. EMBO J 2002; 21: 1031-1040.
5. Bartz JC, Kincaid AE, Bessen RA. Retrograde transport of transmissible mink encephalopathy within descending motor tracts. J Virol 2002; 76: 5759-5768.
6. Bartz JC, Kincaid AE, Bessen RA. Rapid prion neuroinvasion following tongue infection. J Virol 2003; 77: 583-591.
7. Basler K, Oesch B, Scott M, Westaway D, W⊣lchli M, Groth DF, McKinley MP, Prusiner SB, Weissmann C. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 1986; 46: 417-428.
8. Beck E. Lesions akin to transmissible spongiform encephalopathy in the brains of rats inoculated with immature cerebellum. Acta Neuropathol 1988; 76: 295-305.
9. Boellaard JW, Kao M, Schlote W, Diringer H. Neuronal autophagy in experimental scrapie. Acta Neuropathol 1991; 82: 225-228.
10. Bolton DC, McKinley MP, Prusiner SB. identification of a protein that purifies with the scrapie prion. Science 1982; 218: 1309-1311.
11. Borchelt DR, Koliatsos VE, Guarnieri M, Pardo CA, Sisodia SS, Price DL. Rapid anterograde axonal transport of the cellular prion glycoprotein in the peripheral and central nervous systems. J Biol Chem 1994; 269: 14711-14714.
12. Borchelt DR, Scott M, Taraboulos A, Stahl N, Prusiner SB. Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol 1990; 110: 743-752.
13. Borchelt DR, Taraboulos A, Prusiner SB. Evidence for synthesis of scrapie prion protein in the endocytic pathway. J Biol Chem 1992; 267: 16188-16199.
14. Bounhar Y. Prion protein protects human neurons against Bax-mediated apoptosis. J Biol Chem 2001; 276: 39145-39149.
15. Brandner S, Isenmann S, Raeber A, Fischer M, Sailer A, Kobayashi Y, Marino S, Weissmann C, Aguzzi A. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 1996; 379: 339-343.
16. Bratosiewicz-Wasik J, Wasik T, Liberski PP. Molecular approaches to mechanisms of prion diseases. Folia Neuropathol 2004; 42: 33-46.
17. Brown DR. Prion protein-overexpressing cells show altered response to a neurotoxic prion protein peptide. J Neurosci Res 1998; 54: 331-340.
18. Brown DR. Prion protein peptide neurotoxicity can be mediated by astrocytes. J Neurochem 1999; 73: 1105-1113.
19. Brown DR. Prion protein peptides: optimal toxicity and peptide blockade of toxicity. Mol Cell Neurosci 2000; 15: 66-78.
20. Brown DR. PrPSc-like prion protein peptide inhibits the function of cellular prion protein. Biochem J 2000; 352: 511-518.
21. Brown DR, Besinger A. Prion protein expression and superoxide dismutase activity. Biochem J 1998; 334: 423-429.
22. Brown DR, Besinger A, Herms JW, Kretzschmar HA. Microglial expression of the prion protein. Neuroreport 1998; 9: 1425-1429.
23. Brown DR, Herms J, Kretzschmar HA. Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment. Neuroreport 1994; 5: 2057-2060.
24. Brown DR, Herms JW, Schmidt B, Kretzschmar HA. PrP and beta-amyloid fragments activate different neurotoxic mechanisms in cultured mouse cells. Eur J Neurosci 1997; 9: 1162-1169.
25. Brown DR, Mohn CM. Astrocytic glutamate uptake and prion protein expression. Glia 1999; 25: 282-292.
26. Brown DR, Nicholas RS, Canevari L. Lack of prion protein expression results in a neuronal phenotype sensitive to stress. J Neurosci Res 2002; 67: 211-224.
27. Brown DR, Schmidt B, Kretzschmar HA. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature 1996; 380: 345-347.
28. Brown DR, Schmidt B, Kretzschmar HA. A prion protein fragment interacts with PrP-cleficient cells. J Neurosci Res 1998; 52: 260-267.
29. Brown DR, Schmidt B, Kretzschmar HA. Effects of copper on survival of prion protein knockout neurons and glia. J Neurochem 1998; 70: 1686-1693.
30. Brown DR, Schultz-Schaeffer WJ, Schmidt B, Kretzschmar HA. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp Neurol 1997; 146: 104-112.
31. Brown P. The phantasmagoric immunology of transmissible spongiform encephalopathy. in: Waksman BH (ed.). immunologic Mechanisms in Neurologic and Psychiatric Disease. Raven Press, Ltd, New York, 1990; pp. 305-313.
32. Brown P, Cervenáková L. A prion lexicon (out of control). Lancet 2005; 365: 122.
33. Budka H, Head MW, Ironside JW, Gambetti P, Parchi P, Zeidler M, Tagliavini F. Prion Disorders: CJD: Sporadic Creutzfeldt-Jakob disease. In: Dickson D (ed.). Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. ISN Neuropath Press, Basel, 2003: pp. 287-297.
34. Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, Prusiner SB, Aguet M, Weissmann C. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992; 356: 577-582.
35. Burger D, Hartsough GR. A scrapie-like disease of mink. In: Report of a Scrapie Seminar. United States Department of Agriculture, paper 27, 1964; pp. 225-227.
36. Bursch W. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ 2001; 8: 569-581.
37. Bursch W. Multiple cell death programs: Charon's lifts to Hades. FEMS Yeast Res 2004; 5: 101-110.
38. Bursch W, Ellinger A. Autophagy - a basic mechanism and a potential role for neurodegeneration. Folia Neuropathol 2005; 43: 297-310.
39. Bursch W, Ellinger A, Gerner C, Schulte-Hermann R. Autophagocytosis and programmed cell death. In: Klionsky D (ed.). Autophagy. Landes Bioscience, Georgetown, Texas, USA, 2004; pp. 290-306.
40. Bursch W, Hochegger K, Torok L, Marian B, Ettinger A, Hermann RS. Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments. J Cell Sci 2000; 113: 1189-1198.
41. Caughey B, Raymond GJ. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem 1991; 266: 18217-18223.
42. Caughey B, Raymond GJ, Ernst D, Race RE. N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J Virol 1991; 65: 6597-6603.
43. Chen SG, Teplow DB, Parchi P, Teller JK, Gambetti P, Autilio-Gambetti L. Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem 1995; 270: 19173-19180.
44. Chesebro B. Introduction to the transmissible spongiform encephalopathies or prion disease. Brit Med Bull 2003; 63: 1-20.
45. Chesebro B, Race R, Wehrly K, Nishio J, Bloom M, Lechner D, Bergstrom S, Robbins K, Mayer L, Keith JM, et at. Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature 1985; 315: 331-333.
46. Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R, Raymond L, Favara C, Baron G, Priola S, Caughey B, Masliah E, Oldstone M. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 2005; 308: 1435-1439.
47. Cho HJ. Requirement of a protein component for scrapie infectivity. Intervirology 1980; 14: 213-216.
48. Choi SI, Ju WK, Choi EK, Kim J, Lea HZ, Carp RI, Wisniewski HM, Kim YS. Mitochondrial dysfunction induced by oxidative stress in the brains of hamsters infected with the 263 K scrapie agent. Acta Neuropathol 1998; 96: 279-286.
49. Clarke PG. Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol (Berl) 1990; 181: 195-213.
50. Cohen E, Taraboulos A. Scrapie-like prion protein accumulates in aggresomes of cyclosporin A-treated cells. EMBO J 2003; 22: 404-417.
51. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 2001; 24: 519-550.
52. Corsaro A, Thellung S, Villa V, Principe DR, Paludi D, Arena S, Millo E, Schettini D, Damonte G, Aceto A, Schettini G, Florio T. Prion protein fragment 106-126 induces a p38 MAP kinase-dependent apoptosis in SH-SY5Y neuroblastoma cells independently from the amyloid fibril formation. Ann N Y Acad Sci 2003; 1010: 610-622.
53. Cuille J, Chelle P-L. Pathologie animale - la maladie dite tremblante du mouton est-elle inoculable? Comptes rendus des Seances de l'Academie des Sciences (Paris) 1936; 203: 1552-1554.
54. Cuille J, Chelle P-L. La "tremblante" du mouton est bien inoculable. Comptes rendus des Seances de l'Academie des Sciences (Paris) 1938; 206: 78-79.
55. Cunningham AA, Wells GAH, Scott AC, Kirkwood JK, Barnett JEF. Transmissible spongiform encephalopathy in greater kudu (Tragelaphus strepsiceros). Vet Rec 1993; 132: 68.
56. Deleault NR, Lucassen RW, Supattapone S. RNA molecules stimulate prion protein conversion. Nature 2003; 425: 717-720.
57. Dickinson AG. Scrapie in sheep and goats. In: Kimberlin RH (ed.). Slow Virus Diseases of Animals and Man. North-Holland Publ Comp, Amsterdam, 1976; pp. 209-241.
58. Diringer H. Hidden amyloidoses. Exp Clin immunogenet 1992; 9: 212-229.
59. Diringer H, Gelderblom H, Hilmert H, Ozel M, Edelbluth C, Kimberlin RH. Scrapie infectivity, fibrils and low molecular weight protein. Nature 1983; 306: 476-478.
60. Dorandeu A, Wingertsmann L, Chretien F, Delisle M-B, Vital C, Parchi P, Montagna P, Lugaresi E, Ironside JW, Budka H, Gambetti P, Gray F. Neuronal apoptosis in fatal familial insomnia. Brain Pathol 1998; 8: 531-537.
61. Eskelinen EL. Doctor Jekyll and Mister Hyde: autophagy can promote both cell survival and cell death. Cell Death Differ 2005; 12 (Suppl 2): 1468-1472.
62. Fairbairn DW, Carnahan KG, Thwaits RN, Grigsby RV, Holyoak GR, O'Neill KL. Detection of apoptosis induced DNA cleavage in scrapie-infected sheep brain. FEMS Microbiol Lett 1994; 115: 341-346.
63. Ferrer I. Nuclear DNA fragmentation in Creutzfeldt-Jakob disease: does a mere positive in situ nuclear end-labeling indicate apoptosis? Acta Neuropathol (Berl) 1994; 97: 5-12.
64. Fevrier B, Vilette D, Archer F, Loew D, Faigle W, Vidal M, Laude H, Raposo G. Cells release prions in association with exosomes. Proc Natl Acad Sci USA 2004; 101: 9683-9688.
65. Filonova LH, Bozhkov PV, Brukhin VB, Daniel G, Zhivotovsky B, von Arnold S. Two waves of programmed cell death occur during formation and development of somatic embryos in the gymnosperm, Norway spruce. J Cell Sci 2000; 113: 4399-4411.
66. Fink SL, Cookson BT. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun 2005; 73: 1907-1916.
67. Flechsig E, Weissmann C. The role of PrP in health and disease. Curr Mol Med 2004; 4: 337-353.
68. Fleetwood AJ, Furley CW. Spongiform encephalopathy in an eland. Vet Rec 1990; 126: 408-409.
69. Fraser JR. What is the basis of transmissible spongiform encephalopathy induced neurodegeneration and it be repaired? Neuropathol Appl Neurobiol 2002; 28: 1-11.
70. Fraser JR, Halliday WG, Brown D, P Belichenko P, Jeffrey M. Mechanisms of scrapie-induced neuronal cell death. In: Court L, Dodet B (eds.). Transmissible subacute spongiform encephalopathies: prion disease. IIIrd International Symposium on transmissible subacute spongiform encephalopathies: prion disease, Val-de-Grace Paris, France. Elsevier, Amsterdam-Oxford-Paris, 1996; pp. 107-112.
71. Gabriel JM, Oesch B, Kretzschmar H, Scott M, Prusiner SB. Molecular cloning of a candidate chicken prion protein. Proc Natl Acad Sci USA 1992; 89: 9097-9101.
72. Gajdusek DC. Unconventional viruses and the origin and disappearance of kuru. Science 1977; 197: 943-960.
73. Gajdusek DC, Gibbs CJ, Alpers M. Experimental transmission of a kuru-like syndrome to chimpanzees. Nature 1966; 209: 794-796.
74. Garcia-Mata R, Gao YS, Sztul E. Hassles with taking out the garbage: aggravating aggresomes. Traffic 2002; 3: 388-396.
75. Gibbons RA, Hunter GD. Nature of the scrapie agent. Nature 1967; 215: 1041-1043.
76. Gibbs CJ Jr, Gajdusek DC, Asher DM, Alpers MP, Beck E, Daniel PM, Matthews WB. Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to chimpanzee. Science 1968; 161: 388-389.
77. Gibson PH, Liberski PP. An electron and light microscopic study of the numbers of dystrophic neurites and vacuoles in the hippocampus of mice infected intracerebrally with scrapie. Acta Neuropathol 1987; 73: 379-382.
78. Giese A, Brown DR, Groschup MH, Feldmann C, Haist I, Kretzschmar HA. Role of microglia in neuronal cell death in prion disease. Brain Pathol 1998; 8: 449-457.
79. Giese A, Groschup MH, Hess B, Kretzschmar HA. Neuronal cell death in scrapie-infected mice is due to apoptosis. Brain Pathol 1995; 5: 213-221.
80. Giese A, Kretzschmar HA. Prion-induced neuronal damage - the mechanisms of neuronal destruction in the subacute spongiform encephalopathies. Curr Top Microbiol Immunol 2001; 253: 203-217.
81. Glatzel M, Giger O, Braun N, Aguzzi A. The peripheral nervous system and the pathogenesis of prion diseases. Curr Mol Med 2004; 4: 355-359.
82. Gonzalez-Polo RA, Boya P, Pauleau AL, Jalil A, Larochette N, Souquere S, Eskelinen EL, Pierron G, Saftig P, Kroemer G. The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death. J Cell Sci 2005; 118: 3091-3102.
83. Graeber MB, Moran LB. Mechanisms of cell death in neurodegenerative diseases: fashion, fiction, and facts. Brain Pathol 2002; 12: 385-390.
84. Gray F, Chretien F, Adle-Biassette H, Dorandeu A, Ereau T, Delisle M-B, Kopp N, Ironside JW, Vital C. Neuronal apoptosis in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 1999; 58: 321-328.
85. Griffith JS. Self-replication and scrapie. Nature 1967; 215: 1043-1044.
86. Guan Z, Soderberg M, Sindelar P, Prusiner SB, Kristensson K, Dallner G. Lipid composition in scrapie-infected mouse brain: prion infection increases the levels of dolichyl phosphate and ubiquinone. J Neurochem 1996; 66: 277-285.
87. Guentchev M, Voigtländer T, Haberler C, Groschup MH, Budka H. Evidence for oxidative stress in experimental prion disease. Neurobiol Dis 2000; 7: 270-273.
88. Hafiz FB, Brown DR. A model for the mechanism of astrogliosis in prion disease. Mol Cell Neurosci 2000; 16: 221-232.
89. Hainfellner H, Liberski PP, Guiroy DC, Cervenakova L, Brown P, Gajdusek DC, Budka H. Pathology and immunohistochemistry of a Kuru brain. Brain Pathol 1997; 7: 547-554.
90. Hardy J, Scholz S, Evans W, Goldfarb L, Singleton A. Prion genotypes in Central America suggest selection for the V129 allele. Am J Med Genet B Neuropsychiatr Genet 2006; 141: 33-35.
91. Hariri M, Millane G, Guimond M-P, Dennis JW, Nabi IR. Biogenesis of multilamellar bodies via autophagy. Mol Biol Cell 2000; 11: 255-268.
92. Harris DA. Trafficking, turnover and membrane topology of PrP. Br Med Bull 2003; 66: 71-85.
93. Harris DA, Falls DL, Johnson FA, Fischbach GD. A prion-like protein from chicken brain copurifies with an acetylcholine receptor-inducing activity. Proc Natl Acad Sci USA 1991; 88: 7664-7668.
94. Hedge RS, Mastrianni JA, Scott MR, DeFea KA, Tremblay P, Torchia M, DeArmond SJ, Prusiner SB, Lingappa VR. A transmembrane form of the prion protein in neurodegenerative disease. Science 1998; 279: 827-834.
95. Hegde RS, Voigt S, Lingappa VR. Regulation of protein topology by trans-acting factors at the endoplasmic reticulum. Mol Cell 1998; 2: 85-91.
96. Hetz C, Russelakis-Carneiro M, Maundrell K, Castilla J, Soto C. Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J 2003; 22: 5435-5445.
97. Hijazi N, Kariv-Inbal Z, Gasset M, Gabizon R. PrPSc incorporation to cells requires endogenous glycosaminoglycan expression. J Biol Chem 2005; 280: 17057-17061.
98. Horonchik L, Tzaban S, Ben Zaken O, Yedidia Y, Rouvinski A, Papy-Garcia D, Barritault D, Vlodavsky I, Taraboulos A. Heparan sulfate is a cellular receptor for purified infectious prions. J Biol Chem 2005; 280: 17062-17067.
99. Inbal B, Bialik S, Sabanay I, Shani G, Kimchi A. DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death. J Cell Biol 2002; 157: 455-468.
100. Jamieson E, Jeffrey M, Ironside JW, Fraser JR. Apoptosis and dendritic dysfunction precede prion protein accumulation in 87V scrapie. Neuroreport 2001; 12: 2147-2153.
101. Jeffrey M, Fraser JR, Halliday WG, Fowler N, Goodsir CM, Brown DA. Early unsuspected neuron and axon terminal loss in scrapie-infected mice revealed by morphometry and immunohistochemistry. Neuropathol Appl Neurobiol 1995; 21: 41-49.
102. Jeffrey M, Goodbrand IA, Goodsir A. Pathology of the transmissible spongiform encephalopathies with special emphasis on ultrastructure. Micron 1995; 26: 277-298.
103. Jeffrey M, Goodsir CM, Race RE, Chesebro B. Scrapie-specific neuronal lesions are independent of neuronal PrP expression. Ann Neurol 2004; 55: 781-792.
104. Jeffrey M, McGovern G, Goodsir CM, Brown KL, Bruce ME. Sites of prion protein accumulation in scrapie-infected mouse spleen revealed by immuno-electron microscopy. J Pathol 2000; 191: 323-332.
105. Jeffrey M, Scott JR, Williams A, Fraser H. Ultrastructural features of spongiform encephalopathy transmitted to mice from three species of bovidae. Acta Neuropathol 1992; 84: 559-569.
106. Jeffrey M, Wells GA. Spongiform encephalopathy in a Nyala. Vet Pathol 1988; 25: 398-399.
107. Jesionek-Kupnicka D, Buczynski J, Kordek R, Liberski PP. Neuronal loss and apoptosis in experimental Creutzfeldt-Jakob disease in mice. Foiia Neuropathol 1999; 37: 283-286.
108. Jesionek-Kupnicka D, Buczynski J, Kordek R, Sobow T, Kloszewska I, Papierz W, Liberski PP. Programmed cell death (apoptosis) in Alzheimer's disease and Creutzfeldt-Jakob disease. Folia Neuropathol 1997; 35: 233-235.
109. Jesionek-Kupnicka D, Kordek R, Buczynski J, Liberski PP. Apoptosis in relation to neuronal loss in experimental Creutzfeldt-Jakob disease in mice. Acta Neurobiol Exp (Wars) 2001; 61: 13-19.
110. Kegel KB, Kim M, Sapp E, McIntyre C, Castano JG, Aronin N, DiFiglia M. Huntingtin expression stimulates endosomallysosomal activity, endosome tubutation, and autophagy. J Neurosci 2000; 20: 7268-7278.
111. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.
112. Kim JI, Ju WK, Choi JH, Choi E, Carp RI, Wisniewski HM, Kim YS. Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapie-infected mice. Brain Res Mol Brain Res 1999; 73: 17-27.
113. Kimberlin RH. Scrapie and possible relationships with viroids. Sem Virol 1999; 1: 153-162.
114. Kimberlin RH, Field HJ, Walker CA. Pathogenesis of mouse scrapie: evidence for spread of infection from central to peripheral nervous system. J Gen Virol 1983; 64: 713-716.
115. Kirkwood JK, Wells GAH, Cunningham AA, Jackson SI, Scott AC, Dawson M, Wilesmith JW. Scrapie-like encephalopathy in a greater kudu (Tragelaphus strepsiceros) which had not been fed ruminant-derived protein. Vet Res 1992; 130: 365-367.
116. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 2000; 290: 1717-1721.
117. Kopito RR. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 2000; 10: 524-530.
118. Kovacs GG, Preusser M, Strohschneider M, Budka H. Subcellular localization of disease-associated prion protein in the human brain. Am J Pathol 2005; 166: 287-294.
119. Kretzschmar HA, Giese A, Brown DR, Herms J, Keller B, Schmidt B, Groschup MH. Cell death in prion disease. J Neural Transm Suppi 1997; 50: 191-210.
120. Kretzschmar HA, Giese A, Brown DR, Herms J, Schmidt B, Groschup MH. Cell death in prion disease. In: Court L, Dodet B (eds.). Transmissible Subacute Spongiform Encephalopathies: Prion Disease. IIIrd International Symposium on transmissible subacute spongiform encephalopathies: prion disease. Val-de-Grace, Paris, France. Elsevier, Amsterdam-Oxford-Paris, 1996; pp. 97-106.
121. Kretzschmar HA, Giese A, Herms J, Brown DR. Neuronal degeneration and cell death in prion disease. In: Morrison DR (ed.). Prions and Brain Diseases in Animals and Humans. Plenum Press, New York, 1998; pp. 253-268.
122. Kristiansen M, Messenger MJ, Klöhn PC, Brandner S, Wadsworth JD, Collinge J, Tabrizi SJ. Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis. J Biol Chem 2005; 280: 38851-38861.
123. Kroemer G, El-Deiry WS, Golstein P, Peter ME, Vaux D, Vandenabeele P, Zhivotovsky B, Blagosklonny MV, Malorni W, Knight RA, Piacentini M, Nagata S, Melino G. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 2005; 12 (Suppl 2): 1463-1467.
124. Kroemer G, Jaattela M. Lysosomes and autophagy in cell death control. Nat Rev Cancer 2005; 5: 886-897.
125. Künzi V, Glatzel M, Nakano MY, Greber UF, Van Leuven F, Aguzzi A. Unhampered prion neuroinvasion despite impaired fast axonal transport in transgenic mice overexpressing four-repeat tau. J Neurosci 2002; 22: 7471-7477.
126. Kuwahara C, Takeuchi AM, Nishimura T, Haraguchi K, Kubosaki A, Matsumoto Y, Saeki K, Matsumoto Y, Yokoyama T, Itohara S, Onodera T. Prions prevent neuronal cell-line death. Nature 1999; 400: 225-226.
127. Lasmezas CI, Deslys JP, Robain O, Jaegly A, Beringue V, Peyrin JM, Fournier JG, Hauw JJ, Rossier J, Dormont D. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 1997; 275: 402-405.
128. Lee DW, Sohn HO, Lim HB, Lee YG, Kim Y-S, Carp RI, Wisniewski HM. Alteration of free radical metabolism in the brain of mice infected with scrapie agent. Free Radic Res 1999; 30: 499-507.
129. Lee HP, Jun YC, Choi JK, Kim JI, Carp RI, Kim YS. Activation of mitogen-activated protein kinases in hamster brains infected with 263K scrapie agent. J Neurochem 2005; 95: 584-593.
130. Levine P. Scrapie: an infective polypeptide? Lancet 1972; 1: 748.
131. Liberski PP. Electron microscopic observations on dystrophic neurites in hamster brains infected with the 263K strain of scrapie. J Comp Pathol 1987; 97: 35-39.
132. Liberski PP, Asher DM, Yanagihara R, Gibbs CJ Jr, Gajdusek DC. Serial ultrastructural studies of scrapie in hamsters. J Comp Pathol 1989; 101: 429-442.
133. Liberski PP, Budka H. Neuroaxonal pathology in Creutzfeldt-Jakob disease. Acta Neuropathol 1999; 97: 329-334.
134. Liberski PP, Budka H, Yanagihara R, Gajdusek DC. Neuroaxonal dystrophy in experimental Creutzfeldt-Jakob disease: electron microscopical and immunohistochemical demonstration of neurofilament accumulations within affected neurites. J Comp Pathol 1995; 112: 243-255.
135. Liberski PP, Gajdusek DC. Kuru: forty years later. Brain Pathol 1997; 7: 555-560.
136. Liberski PP, Gajdusek DC, Brown P. How do neurons degenerate in prion diseases or transmissible spongiform encephalopathies (TSEs): neuronal autophagy revisited. Acta Neurobiol Exp (Wars) 2002; 62: 141-147.
137. Liberski PP, Guiroy DC, Williams ES, Walis A, Budka H. Deposition patterns of disease-associated prion protein in captive mule deer brains with chronic wasting disease. Acta Neuropathol 2001; 102: 496-500.
138. Liberski PP, Ironside JW. An outline of the neuropathology of transmissible spongiform encephalopathies (prion diseases). Folia Neuropathol 2004; 42 (Suppl B): 39-58.
139. Liberski PP, Jaskolski M. Prion diseases: a dual view of the prion hypothesis as seen from a distance. Acta Neurobiol Exp (Wars) 2002; 62: 197-224.
140. Liberski PP, Jeffrey M. Tubulovesicular structures - the ultrastructural hallmark for transmissible spongiform encephalopathies or prion diseases. Folia Neuropathol 2004; 42 (Suppl B): 96-108.
141. Liberski PP, Kloszewska I, Boellaard I, Papierz W, Omulecka A, Budka H. Dystrophic neurites of Alzheimer's disease and Gerstmann-Sträussler-Scheinker's disease dissociate from the formation of paired helical filaments. Alzheimer's Res 1995; 1: 89-93.
142. Liberski PP, Mori S. The Echigo-1: a panencephalopathic strain of Creutzfeldt-Jakob disease: a passage to hamsters and ultrastructural studies. Folia Neuropathol 1997; 35: 250-254.
143. Liberski PP, Sikorska B, Bratosiewicz-Wasik J, Gajdusek DC, Brown P. Neuronal cell death in transmissible spongiform encephalopathies (prion diseases) revisited: from apoptosis to autophagy. Int J Biochem Cell Biol 2004; 36: 2473-2490.
144. Liberski PP, Streichenberger N, Giraud P, Soutrenon M, Meyronnet D, Sikorska B, Kopp N. Ultrastructural pathology of prion diseases revisited: brain biopsy studies. Neuropathol Appi Neurobiol 2005; 31: 88-96.
145. Liberski PP, Yanagihara R, Gibbs CJ Jr, Gajdusek DC. Neuronal autophagic vacuoles in experimental scrapie and Creutzfeldt-Jakob disease. Acta Neuropathol 1992; 83: 134-139.
146. Lucassen PJ, Williams A, Chung WC, Fraser H. Detection of apoptosis in murine scrapie. Neurosci Lett 1995; 198: 185-188.
147. Lugaresi E, Medori R, Montagna P, Baruzzi A, Cortelli P, Lugaresi A, Tinuper P, Zucconi M, Gambetti P. Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. New Engl J Med 1986; 315: 997-1003.
148. Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T, Thompson CB. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 2005; 120: 237-248.
149. Magalhaes AC, Baron GS, Lee KS, Steele-Mortimer O, Dorward D, Prado MA, Caughey B. Uptake and neuritic transport of scrapie prion protein coincident with infection of neuronal cells. J Neurosci 2005; 25: 5207-5216.
150. Magalhaes AC, Silva JA, Lee KS, Martins VR, Prado VF, Ferguson SS, Gomez MV, Brentani RR, Prado MA. Endocytic intermediates involved with the intracellular trafficking of a fluorescent cellular prion protein. J Biol Chem 2002; 277: 33311-33318.
151. Mallucci G, Dickinson A, Linehan J, Klohn PC, Brandner S, Collinge J. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 2003; 302: 871-874.
152. Manuelidis L. A virus behind the mask of prions? Folia Neuropathol 2004; 42 (Suppl B): 10-23.
153. Manuelidis L. A 25 nm virion is the likely cause of transmissible spongiform encephalopathies. J Cell Biochem 2007; 100: 897-915.
154. Manuelidis L, Sklaviadis T, Manuelidis EE. Evidence suggesting that PrP is not the infectious agent in Creutzfeldt-Jakob disease. EMBO J 1987; 6: 341-347.
155. Marella M, Chabry J. Neurons and astrocytes respond to prion infection by inducing microglia recruitment. J Neurosci 2004; 24: 620-627.
156. Marella M, Gaggioli C, Batoz M, Deckert M, Tartare-Deckert S, Chabry J. Pathological prion protein exposure switches on neuronal mitogen-activated protein kinase pathway resulting in microglia recruitment. J Biol Chem 2005; 280: 1529-1534.
157. Masters CL, Gajdusek DC, Gibbs CJ Jr. Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Sträussler syndrome. With an analysis of the various forms of amyloid plaque deposition in the virus induced spongiform encephalopathies. Brain 1981; 104: 559-588.
158. Matsumura H, Shimizu Y, Ohsawa Y, Kawahara A, Uchiyama Y, Nagata S. Necrotic death pathway in Fas receptor signaling. J Cell Biol 2000; 151: 1247-1256.
159. McBride PA, Schutz-Schaeffer WJ, Donaldson M, Bruce M, Diringer H, Kretzschmar HA, Beekes M. Early spread of scrapie from the gastrointestinal tract to the central nervous system involves autonomic fibers of the splanchnic and vagus nerves. J Virol 2001; 75: 9320-9327.
160. McHattie SJ, Brown DR, Bird MM. Cellular uptake of the prion protein fragment PrP106-126 in vitro. J Neurocytol 1999; 28: 149-159.
161. McKinley MP, Bolton DC, Prusiner SB. A protease resistant protein is a structural component of the scrapie prion. Cell 1983; 35: 57-62.
162. Melino G, Knight RA, Nicotera P. How many ways to die? How many different models of cell death? Cell Death Differ 2005; 12 (Suppl 2): 1457-1462.
163. Merz PA, Rohwer RG, Kascsak R, Wisniewski HM, Somerville RA, Gibbs CJ Jr, Gajdusek DC. infection specific particle from the unconventional slow virus diseases. Science 1984; 225: 437-440.
164. Merz PA, Somerville RA, Wisniewski HM, Iqbal K. Abnormal fibrils from scrapie-infected brain. Acta Neuropathol 1981; 54: 63-74.
165. Migheli A, Attanasio A, Lee WH, Bayer SA, Ghetti B. Detection of apoptosis in weaver cerebellum by electron microscopic in situ end-labeling of fragmented DNA Neurosci Lett 1995; 199: 53-56.
166. Millson GC, Hunter GD, Kimberlin RH. The physico-chemical nature of the scrapie agent. In: Kimberlin RH (ed.). Slow Virus Diseases of Animals and Man. North-Holland Publ Comp, Amsterdam, 1976; pp. 243-266.
167. Mishra RS, Basu S, Gu Y, Luo X, Zou WQ, Mishra R, Li R, Chen SG, Gambetti P, Fujioka H, Singh N. Protease-resistant human prion protein and ferritin are cotransported across Caco-2 epithelial cells: implications for species barrier in prion uptake from the intestine. J Neurosci 2004; 24: 11280-11290.
168. Moran LB, Kosel S, Spitzer C, Schwaiger FW, Riess O, Kreutzberg GW, Graeber MB. Expression of alpha-synuclein in non-apoptotic, slowly degenerating facial motoneurones. J Neurocytol 2001; 30: 515-521.
169. Morel E, Andrieu T, Casagrande F, Gauczynski S, Weiss S, Grassi J, Rousset M, Dormont D, Chambaz J. Bovine prion is endocytosed by human enterocytes via the 37 kDa/67 kDa laminin receptor. Am J Pathol 2005; 167: 1033-1042.
170. Moya KL, Hässig R, Breen KC, Volland H, Di Giamberardino L. Axonal transport of the cellular prion protein is increased during axon regeneration. J Neurochem 2005; 92: 1044-1053.
171. Moya KL, Hässig R, Créminon C, Laffont I, Di Giamberardino L. Enhanced detection and retrograde axonal transport of PrPc in peripheral nerve. J Neurochem 2004; 88: 155-160.
172. Muller WE, Ushijima H, Schroder HC, Forrest JM, Schatton WF, Rytik PG, Heffner-Lauc M. Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell cultures. Eur J Pharmacol 1993; 246: 261-267.
173. Myohara M. Real-time observation of autophagic programmed cell death of Drosophila salivary glands in vitro. Dev Genes Evol 2004; 214: 99-104.
174. Nixon RA, Wegiel J, Kumar A, Yu WH, Peterhoff C, Cataldo A, Cuervo AM. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol 2005; 64: 113-122.
175. O'Donovan CN, Tobin D, Cotter TG. Prion protein fragment PrP-(106-126) induces apoptosis via mitochondrial disruption in human neuronal SH-SY5Y cells. J Biol Chem 2001; 276: 43516-43523.
176. Oesch B, Westaway D, Wälchli M, McKinley MP, Kent SB, Aebersold R, Barry RA, Tempst P, Teptow DB, Hood LE, et al. A cellular gene encodes scrapie PrP 27-30 protein. Cell 1985; 40: 735-746.
177. Oidtmann B, Simon D, Holtkamp N, Hoffmann R, Baier M. Identification of cDNAs from Japanese pufferfish (Fugu rubripes) and Atlantic salmon (Saimo salar) coding for homologues to tetrapod prion proteins. FEBS Lett 2003; 538: 96-100.
178. Peretz D, Williamson RA, Kaneko K, Vergara J, Leclerc E, Schmitt-Ulms G, Mehlhorn IR, Legname G, Wormald MR, Rudd PM, Dwek RA, Burton DR, Prusiner SB. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 2001; 412: 739-743.
179. Pillot T, Drouet B, Pinçon-Raymond M, Vandekerckhove J, Rosseneu M, Chambaz J. A nonfibrillar from of the fusogenic prion protein fragment (118-135) induces apoptotic cell death in rat cortical neurons. J Neurochem 2000; 75: 2298-2308.
180. Prado MA, Alves-Silva J, Magalhaes AC, Prado VF, Linden R, Martins VR, Brentani RR. PrPc on the road: trafficking of the cellular prion protein. J Neurochem 2004; 88: 769-781.
181. Prusiner SB. Novel proteinaceous infection particles cause scrapie. Science 1982; 216: 136-144.
182. Prusiner SB. Terminology. In: Prusiner SB, McKinley MP (eds.). Prions. Novel Infectious Pathogens Causing Scrapie and Creutzfeldt-Jakob Disease. Academic Press, New York, 1987; pp. 38-53.
183. Prusiner SB. Shattuck lecture - neurodegenerative diseases and prions. N Engl J Med 2001; 344: 1516-1526.
184. Prusiner SB (ed.). Prion Biology and Diseases. University of California, San Francisco, 2004.
185. Prusiner SB, McKinley MP, Bowman KA, Bolton DC, Bendheim PE, Groth DF, Glenner GG. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 1983; 35: 349-358.
186. Race R, Oldstone M, Chesebro B. Entry versus blockade of brain infection following oral or intraperitoneal scrapie administration: role of PrP expression in peripheral nerves and spleen. J Virol 2000; 74: 828-833.
187. Raeber AJ, Race RE, Brandner S, Priola SA, Sailer A, Bessen RA, Mucke L, Manson J, Aguzzi A, Oldstone MB, Weissmann C, Chesebro B. Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie. EMBO J 1997; 16: 6057-6065.
188. Raina AK, Zhu X, Smith MA. Alzheimer's disease and the cell cycle. Acta Neurobiol Exp (Wars) 2004; 64: 107-112.
189. Reggiori F, Klionsky DJ. Autophagy in the eukaryotic cell. Eukaryot Cell 2002; 1: 11-21.
190. Rieger R, Edenhofer F, Lasmezas CI, Weiss S. The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells. Nat Med 1997; 3: 1383-1388.
191. Saez-Valero J, Angeretti N, Forloni G. Caspase-3 activation by beta-amyloid and prion protein peptides is independent from their neurotoxic effect. Neurosci Lett 2000; 293: 207-210.
192. Sattler T, Mayer A. Cell-free reconstitution of microautophagic vacuole invagination and vesicle formation. J Cell Biol 2000; 151: 529-538.
193. Schatzl HM, Da Costa M, Taylor L, Cohen FE, Prusiner SB. Prion protein gene variation among primates. J Mol Biol 1995; 45: 362-374.
194. Schatzl HM, Da Costa M, Taylor L, Cohen FE, Prusiner SB. Prion protein gene variation among primates. J Mol Biol 1997; 265: 257.
195. Schatzl HM, Laszlo L, Holtzman DM, Tatzelt J, DeArmond SJ, Weiner RI, Mobley WC, Prusiner SB. A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. J Virol 1997; 71: 8821-8831.
196. Schulz-Schaeffer WJ, Tschoke S, Kranefuss N, Drose W, Hause-Reitner D, Giese A, Groschup MH, Kretzschmar HA. The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am J Pathol 2000; 156: 51-56.
197. Schweichel JU, Merker HJ. The morphology of various types of cell death in prenatal tissues. Teratology 1973; 7: 253-266.
198. Shyng S-L, Huber MT, Harris DA. A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. J Biol Chem 1993; 268: 15922-15928.
199. Sikorska B, Liberski PP, Giraud P, Kopp N, Brown P. Autophagy is a part of ultrastructural synaptic pathology in Creutzfeldt-Jakob disease: a brain biopsy study. Int J Biochem Cell Biol 2004; 36: 2563-2573.
200. Simonic T, Duga S, Strumbo B, Asselta R. cDNA cloning of turtle prion protein. FEBS Lett 2000; 469: 33-38.
201. Siso S, Puig B, Varea R, Vidal E, Acin C, Prinz M, Montrasio F, Badiola J, Aguzzi A, Pumarola M, Ferrer I. Abnormal synaptic protein expression and cell death in murine scrapie. Acta Neuropathol 2002; 103: 615-626.
202. Soidevila M, Andres AM, Ramirez-Soriano A, Marques-Bonet T, Calafell F, Navarro A, Bertranpetit J. The prion protein gene in humans revisited: lessons from a worldwide resequencing study. Genome Res 2006; 16: 231-239.
203. Solforosi L, Criado JR, McGavern DB, Wirz S, Sanchez-Alavez M, Sugama S, DeGiorgio LA, Volpe BT, Wiseman E, Abalos G, Masliah E, Gilden D, Oldstone MB, Conti B, Williamson RA. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 2004; 303: 1514-1516.
204. Sparkes RS, Simon M, Cohn VH, Fournier RE, Lem J, Klisak I, Heinzmann C, Blatt C, Lucero M, Mohandas T, et al. Assignment of the human and mouse prion protein genes to homologous chromosomes. Proc Natl Acad Sci USA 1986; 83: 7358-7362.
205. Sperandio S, de Belle I, Bredesen DE. An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci USA 2000; 97: 14376-14381.
206. Stadelmann C, Deckwerth TL, Srinivasan A, Bancher C, Bruck W, Jellinger K, Lassmann H. Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. Am J Pathol 1999; 155: 1459-1466.
207. Stahl N, Baldwin MA, Hecker R, Pan K-M, Burlingame AL, Prusiner SB. Glycosylinsoitol phospholipid anchors of the scrapie and cellular prion proteins contain sialic acid. Biochemistry 1992; 31: 5043-5053.
208. Stahl N, Borchelt DR, Prusiner SB. Differential release of cellular and scrapie prion proteins from cellular membranes by phosphatidylinositol-specific phospholipase C. Biochemistry 1990; 29: 5405-5412.
209. Strumbo, B, Ronchi S, Bolis LC, Simonic T. Molecular cloning of the cDNA coding for Xenopus laevis prion. FEBS Lett 2001; 508: 170-174.
210. Stumpf MP, Krakauer DC. Mapping the parameters of prion-induced neuropathology. Proc Natl Acad Sci USA 2000; 97: 10573-10577.
211. Tarabulos A, Jendroska K, Serban D, Yang S-L, DeArmond SJ, Prusiner SB (1992) Regional mapping of prion protein in brain. Proc Natl Acad Sci USA 89: 7620-7624.
212. Theil D, Fatzer R, Meyer R, Schobesberger M, Zurbriggen A, Vandevelde M. Nuclear DNA fragmentation and immune reactivity in bovine spongiform encephalopathy. J Comp Pathol 1999; 121: 357-367.
213. Thellung S, Florio T, Villa V, Corsaro A, Arena S, Amico C, Robello M, Salmona M, Forloni G, Bugiani O, Tagliavini F, Schettini G. Apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in rat cerebellar granule cells treated with the prion protein fragment 106-126. Neurobiol Dis 2000; 7: 299-309.
214. van Rheede T, Smolenaars MM, Madsen O, de Jong WW. Molecular evolution of the mammalian prion protein. Mol Biol Evol 2003; 20: 111-121.
215. Wang C-W, Klionsky DJ. The molecular mechanism of autophagy. Mol Med 2003; 9: 65-76.
216. Weissmann C. A "unified theory" of prion propagation. Nature 2000; 352: 679-683.
217. Weissmann C. The state of the prion. Nat Rev Microbiol 2004; 2: 861-871.
218. Wells GA, Scott AC, Johnson CT, Gunning RF, Hancock RD, Jeffrey M, Dawson M, Bradley R. A novel progressive spongiform encephalopathy in cattle. Vet Rec 1987; 121: 419-420.
219. White AR, Collins SJ, Maher F, Jobling MF, Stewart LR, Thyer JM, Beyreuther K, Masters CL, Cappai R. Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity. Am J Pathol 1999; 155: 1723-1730.
220. Williams A, Lucassen PJ, Ritchie D, Bruce M. PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie. Exp Neurol 1997; 144: 433-438.
221. Williams ES, Young S. Chronic wasting disease of captive mule deer: a spongiform encephalopathy. J Wildl Dis 1980; 16: 89-98.
222. Williams ES, Young S. Spongiform encephalopathy of Rocky Mountain elk. J Wildl Dis 1982; 18: 465-471.
223. Willoughby K, Kelly DF, Lyon DG, Wells GA. Spongiform encephalopathy in a captive puma (Felis concolor). Vet Rec 1992; 131: 431-434.
224. Wood JL, Lund LJ, Done SH. The natural occurrence of scrapie in moufflon. Vet Rec 1992; 130: 25-27.
225. Wopfner F, Weidenhofer G, Schneider R, von Brunn A, Gilch S, Schwarz TF, Werner T, Schatzl HM. Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein. J Mol Biol 1999; 289: 1163-1178.
226. Wyatt JM, Pearson GR, Smerdon TN, Gruffydd-Jones TJ, Wells GA, Wilesmith JW. Naturally occurring scrapie-like spongiform encephalopathy in five domestic cats. Vet Rec 1991; 129: 233-236.
227. Xue L, Fletcher GC, Tolkovsky AM. Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution. Mol Cell Neurosci 1999; 14: 180-198.
228. Yakovlev AG, Faden AI. Mechanisms of neural cell death: implications for development of neuroprotective treatment strategies. NeuroRx 2004; 1: 5-16.
229. Ye X, Scallet AC, Kascsak RJ, Carp RI. Astrocytosis and amyloid deposition in scrapie-infected hamsters. Brain Res 1998; 809: 277-287.
230. Yuan J, Lipinski M, Degterev A. Diversity of the mechanisms of neuronal cell death. Neuron 2003; 40: 401-413.
231. Zanata SM, Lopes MH, Mercadante AF, Hajj GN, Chiarini LB, Nomizo R, Freitas AR, Cabral AL, Lee KS, Juliano MA, de Oliveira E, Jachieri SG, Burlingame A, Huang L, Linden R, Brentani RR, Martins VR. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J 2002; 21: 3307-3316.